XETRA - Delayed Quote EUR

AlzChem Group AG (ACT.DE)

127.20
-1.60
(-1.24%)
At close: May 9 at 5:35:14 PM GMT+2
Loading Chart for ACT.DE
  • Previous Close 128.80
  • Open 127.80
  • Bid --
  • Ask --
  • Day's Range 124.00 - 128.40
  • 52 Week Range 39.20 - 132.60
  • Volume 40,409
  • Avg. Volume 43,220
  • Market Cap (intraday) 1.299B
  • Beta (5Y Monthly) 0.82
  • PE Ratio (TTM) 24.00
  • EPS (TTM) 5.30
  • Earnings Date Jul 30, 2025
  • Forward Dividend & Yield 1.80 (1.42%)
  • Ex-Dividend Date May 9, 2025
  • 1y Target Est 117.40

AlzChem Group AG, together with its subsidiaries, develops, produces, and markets a range of chemical specialties in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. It operates through three segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The Specialty Chemicals segment sells specialty chemical products that are used in the chemical, food, animal feed, defence technology, and renewable energies industries. This segment manufactures composite materials and adhesives, as well as silicon nitride for ceramics; and photovoltaic modules in the solar industry. The Basics & Intermediates segment produces raw materials for specialty chemicals; and products for agriculture and metallurgy, as well as intermediates for the chemical industry that are produced from lime, carbon, and electricity. This segment also engages in the production and sale of guanidine salts as a raw material for agrochemicals and active pharmaceutical ingredients. The Other & Holding segment provides chemical park operations and administrative services, as well as produces and distributes various infrastructure services. It offers products and services to agricultural sector under the CALCIUM CYANAMIDE PERLKA, EMINEX, DORMEX, ALZOGUR, SITOFEX, and BREAK-THRU brands; animal nutrition sector under the CREAMINO brands; human nutrition sector under the CREAPURE, CREAVITALIS, LIVADUR, and ALIPURE brands; pharma sector under the GUANIDINE SALTS – BIOSELECT brand; fine chemicals sector under the GUANIDINSALZE -BIOSELECT, CYANAMIDE, DICYANDIAMIDE, GUANAMINE, NITRILES, MELFLOCK and ALZOFIX, THIOUREA, and NITROGUANIDINE brands; metallurgy sector under the CAD, CALCIPRO, and CALZOT brands, as well as technical gases and calcium carbide; renewable energy sector under the DYHARD and SILZOT brands; and custom synthesis, such as toll micronization and manufacturing. The company was founded in 1908 and is based in Trostberg, Germany.

www.alzchem.com

1,541

Full Time Employees

December 31

Fiscal Year Ends

Recent News: ACT.DE

View More

Performance Overview: ACT.DE

Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is DAX P (^GDAXI) .

YTD Return

ACT.DE
126.32%
DAX P (^GDAXI)
18.03%

1-Year Return

ACT.DE
197.93%
DAX P (^GDAXI)
25.75%

3-Year Return

ACT.DE
540.37%
DAX P (^GDAXI)
75.62%

5-Year Return

ACT.DE
841.65%
DAX P (^GDAXI)
115.50%

Compare To: ACT.DE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ACT.DE

View More

Valuation Measures

Annual
As of 5/9/2025
  • Market Cap

    1.30B

  • Enterprise Value

    1.29B

  • Trailing P/E

    23.95

  • Forward P/E

    21.69

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.34

  • Price/Book (mrq)

    6.28

  • Enterprise Value/Revenue

    2.33

  • Enterprise Value/EBITDA

    11.99

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    10.09%

  • Return on Assets (ttm)

    9.63%

  • Return on Equity (ttm)

    28.19%

  • Revenue (ttm)

    559.76M

  • Net Income Avi to Common (ttm)

    56.47M

  • Diluted EPS (ttm)

    5.30

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    91.37M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    33.73M

Research Analysis: ACT.DE

View More

Company Insights: ACT.DE

Research Reports: ACT.DE

View More

People Also Watch